Morpholino

MO1-gan

ID
ZDB-MRPHLNO-200528-1
Name
MO1-gan
Previous Names
  • ex2-3 (1)
Target
Sequence
5' - AGAGTGATCTACAGAAGGAAACAGT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-gan
Expressed Gene Anatomy Figures
ptch2 Fig. 5 from Arribat et al., 2019
Phenotype
Phenotype resulting from MO1-gan
Phenotype Fish Figures
CaP motoneuron axon decreased length, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
extension absent, abnormal AB + MO1-gan Fig. S3 from Arribat et al., 2019
eye atrophied, abnormal AB + MO1-gan Fig. S3 from Arribat et al., 2019
head atrophied, abnormal AB + MO1-gan Fig. S3 from Arribat et al., 2019
heart deformed, abnormal AB + MO1-gan Fig. S3 from Arribat et al., 2019
MiP motor neuron axon absent, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
MiP motor neuron axon znp-1 labeling decreased amount, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
MiP motor neuron axon znp-1 labeling decreased distribution, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
neuromuscular junction development arrested, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
primary motor neuron decreased amount, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
primary motor neuron axon znp-1 labeling decreased amount, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
primary motor neuron axon znp-1 labeling decreased distribution, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
primary motor neuron axon irregular spatial pattern, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
RoP motor neuron znp-1 labeling decreased amount, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
RoP motor neuron znp-1 labeling decreased distribution, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
RoP motor neuron axon absent, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
secondary motor neuron decreased amount, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
secondary motor neuron axon absent, abnormal AB + MO1-gan Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron axon zn-8 labeling decreased amount, abnormal AB + MO1-gan Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron axon zn-8 labeling decreased distribution, abnormal AB + MO1-gan Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron cell body absent, abnormal AB + MO1-gan Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron cell body ab2-isl labeling decreased amount, abnormal AB + MO1-gan Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron cell body ab2-isl labeling decreased distribution, abnormal AB + MO1-gan Fig. 2Fig. 4 from Arribat et al., 2019
somite U-shaped, abnormal AB + MO1-gan Fig. 4 from Arribat et al., 2019
somite border ab1-dmd labeling spatial pattern, abnormal AB + MO1-gan Fig. 4 from Arribat et al., 2019
spinal cord ptch2 expression decreased amount, abnormal AB + MO1-gan Fig. 5 from Arribat et al., 2019
spinal cord axon protruding, abnormal AB + MO1-gan Fig. 2 from Arribat et al., 2019
whole organism decreased length, abnormal AB + MO1-gan Fig. S3 from Arribat et al., 2019
whole organism locomotion decreased process quality, abnormal AB + MO1-gan Fig. 1 from Arribat et al., 2019
whole organism motor behavior decreased process quality, abnormal AB + MO1-gan Fig. 1 from Arribat et al., 2019
Phenotype of all Fish created by or utilizing MO1-gan
Phenotype Fish Conditions Figures
somite U-shaped, abnormal AB + MO1-gan control Fig. 4 from Arribat et al., 2019
neuromuscular junction development arrested, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
RoP motor neuron znp-1 labeling decreased distribution, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
MiP motor neuron axon znp-1 labeling decreased distribution, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
primary motor neuron axon irregular spatial pattern, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
secondary motor neuron cell body ab2-isl labeling spatial pattern, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
whole organism decreased length, abnormal AB + MO1-gan control Fig. S3 from Arribat et al., 2019
primary motor neuron axon znp-1 labeling decreased distribution, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
secondary motor neuron axon zn-8 labeling decreased distribution, abnormal AB + MO1-gan control Fig. 2Fig. 4 from Arribat et al., 2019
whole organism locomotion decreased process quality, abnormal AB + MO1-gan control Fig. 1 from Arribat et al., 2019
whole organism motor behavior decreased process quality, abnormal AB + MO1-gan control Fig. 1 from Arribat et al., 2019
eye atrophied, abnormal AB + MO1-gan control Fig. S3 from Arribat et al., 2019
secondary motor neuron cell body spatial pattern, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
RoP motor neuron znp-1 labeling decreased amount, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
extension absent, abnormal AB + MO1-gan control Fig. S3 from Arribat et al., 2019
secondary motor neuron axon zn-8 labeling decreased amount, abnormal AB + MO1-gan control Fig. 2Fig. 4 from Arribat et al., 2019
CaP motoneuron axon decreased length, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
secondary motor neuron cell body ab2-isl labeling amount, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
secondary motor neuron axon zn-8 labeling spatial pattern, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
heart deformed, abnormal AB + MO1-gan control Fig. S3 from Arribat et al., 2019
MiP motor neuron axon znp-1 labeling decreased amount, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
secondary motor neuron cell body ab2-isl labeling decreased distribution, abnormal AB + MO1-gan control Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron axon absent, abnormal AB + MO1-gan control Fig. 2Fig. 4 from Arribat et al., 2019
primary motor neuron decreased amount, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
spinal cord ptch2 expression decreased amount, abnormal AB + MO1-gan control Fig. 5 from Arribat et al., 2019
MiP motor neuron axon absent, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
somite border ab1-dmd labeling spatial pattern, abnormal AB + MO1-gan control Fig. 4 from Arribat et al., 2019
RoP motor neuron axon absent, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
head atrophied, abnormal AB + MO1-gan control Fig. S3 from Arribat et al., 2019
secondary motor neuron cell body absent, abnormal AB + MO1-gan control Fig. 2Fig. 4 from Arribat et al., 2019
secondary motor neuron cell body ab2-isl labeling decreased amount, abnormal AB + MO1-gan control Fig. 2Fig. 4 from Arribat et al., 2019
spinal cord axon protruding, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
secondary motor neuron axon zn-8 labeling amount, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
secondary motor neuron decreased amount, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
secondary motor neuron axon spatial pattern, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
primary motor neuron axon znp-1 labeling decreased amount, abnormal AB + MO1-gan control Fig. 2 from Arribat et al., 2019
somite shape, ameliorated AB + MO1-gan chemical treatment: purmorphamine Fig. 4 from Arribat et al., 2019
Citations